Ohio State Medical Center, James Cancer Center

Columbus, Ohio 43210

1 studies enrolling now · 4 studies all time

What they study most

Acute Biphenotypic Leukemia (ABL), Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma, Acute Myelogenous Leukemia, Acute Myelogenous Leukemia (AML), Acute Undifferentiated Leukemia (AUL), Chemotherapy-sensitive Lymphoma, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic Myelogenous Leukemia, Healthy Donors

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide — Running, not enrolling
• HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide — Completed
• MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies — Stopped early